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424 ROTATIONAL ORIENTATION OF THE CARBOXYL AND tert-BUTYL GROUPS 
Wepster, 1980). A more recent MM2 force field found 
the symmetrical geometry (to = 0 °) to be the more 
stable one (Burkert & Allinger, 1982), and it would 
appear that the twisted tert-butyl group is an artefact 
of the earlier force fields. 
Packing 
The packing of TRANS in the crystal is illustrated in 
Fig. 6. Two carboxyl groups form the well-known 
eight-membered ring around a centre of symmetry. 
The geometry of the hydrogen-bonding scheme is 
added in Table 2. 
The authors are indebted to Professors B. M. Wep- 
ster and H. van Bekkum, Dr J. M. A. Baas and Dr 
A. J. van den Berg for their critical reading and 
discussion of the manuscript. 
c 
Fig. 6. Drawing of the unit-cell contents viewed own b. Hydrogen 
bonds are indicated by broken lines. 
References 
ALLEN, F. H. (1980). Acta Cryst. B36, 81-96. 
ALLEN, F. H., BELLARD, S., BRICE, M. D., CARTWRIGHT, B. A., 
DOUBLEDAY, A., HIGGS, H., HUMMELINK, T., HUMMELINK- 
PETERS, B. G., KENNARD, O., MOTHERWELL, W. D. S., 
RODGERS, J. R. & WATSON, D. G. (1979). Acta Cryst. B35, 
2331-2339. 
ALTONA, C. & SUNDARALINGAM, M. (1970). Tetrahedron, 26, 
925-939. 
BAAS, J. M. A., VAN DE GRAAF, B., VAN VEEN, A. & WEPSTER, 
B. M. (1980). Recl Tray. Chim. Pays-Bas, 99, 228-233. 
BEKKUM, H. VAN (1970). Thesis. Delft Univ. of Technology. 
BEKKUM, H. VAN, VERKADE, P. E. & WEPSTER, B. M. (1966). 
Tetrahedron Lett. No. 13, pp. 1401-1407. 
BURKERT, U. & ALLINGER, N. L. (1982). Molecular Mechanics. 
ACS Monogr. No. 177, 96-97. 
CROMER, D. T. & MANN, J. B. (1968). Acta Cryst. A24, 321-324. 
DUNITZ, J. D. & STRICKLER, P. (1968). Structural Chemistry and 
Molecular Biology, edited by A. RICH & N. DAVlDSON, pp. 
595--602. San Francisco: Freeman. 
GRAAF, B. VAN DE, BAAS, J. M. A. & WEPSTER, B. M. (1978). 
Recl Tray. Chim. Pays-Bas, 97, 268-273. 
JOHNSON, C. K. (1965). ORTEP. Report ORN .L-3794, revised June 
1970. Oak Ridge National Laboratory, Tennessee. 
KANTERS, J. A., KROON, J., PEERDEMAN, A. F. & SCHOONE, J. 
C. (1967). Tetrahedron, 23, 4027-4033. 
KONINGSVELD, H. VAN (1972). Acta Cryst. B28, 1189-1195. 
LElSEROWlTZ, L. (1976). Acta Cryst. B32, 775-802. 
LEISEROWITZ, L. & SCHM1DT, G. M. J. (1965). Acta Crvst. 18, 
1058-1067. 
SICHER, J., TICH~', M. & SIPOS, F. (1966a). Tetrahedron Lett. No. 
13, pp. 1393-1399. 
StCHER, J., TICH~', M. & SIPOS, F. (1966b). Coll. Czech. Chem. 
Commun. 31, 2238-2256. 
STEWART, J. M., KRUGER, G. J., AMMON, H. L., DICKINSON, 
C. W. & HALL, S. R. (1972). XRA Y72 system. Tech. Rep. TR- 192. 
Computer Science Center, Univ. of Maryland, College Park, 
Maryland. 
STEWART, R. F., DAVlDSON, E. R. & SIMPSON, W. T. (1965). J. 
Chem. Phys. 42, 3175-3187. 
Acta Cryst. (1984). B40, 424-429 
Nucle ic  Acid Binding Drugs.  X.* A Theoret ical  Study of  Prof lavine Intercalat ion into 
RNA and DNA Fragments:  Compar ison with Crystal lographic Results 
By S. A. ISLAM AND S. NEIDLE't" 
Cancer Research Campaign Biomolecular Structure Research Group, Department of Biophysics, King's College, 
University of London, 26-29 Drury Lane, London WC2B 5RL, England 
(Received 17 August 1983; accepted 18 January 1984) 
Abstract 
The minimum-energy structure for the interactions of 
the intercalation drug proflavine with the dinucleo- 
side phosphates cytidylyl-3',5'-guanosine and deoxy- 
cytidylyl-3',5'-deoxyguanosine have been found by 
means of a combination of computer graphics and 
* Part IX: Aggarwal, Neidle & Sainsbury (1983). 
t To whom correspondence should be addressed. 
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empirical energy calculations. The minimum-energy 
positions for the drug, given the crystallographically 
observed nucleotide backbone conformations as 
starting points, are very close to the positions in the 
crystal structures of the complexes, with the interca- 
lated proflavine molecule inserted from the major- 
groove direction in each case. Alternative orientations 
for the drug were found to be much less stable. NMR 
studies in solution [Patel (1979). Biopolymers, 16, 
O 1984 International Union of Crystallography 
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2739-2754; Patel & Canuel (1977). Proc. Natl Acad. 
Sci. USA, 74, 2624-2628] are fully consistent with 
these observations. The finding in this study of close 
correspondence between observed and calculated 
structures for the drug complexes implies that the 
'soft' parameterization f the force field used here, 
with its considerable advantages in computational 
speed over a more rigorous approach, may be 
especially helpful in combined molecular graphics 
and energetic approaches to drug-receptor binding. 
conformation, what are the low-energy positions that 
proflavine, an archetypal intercalating drug, would 
adopt? Furthermore, the correspondence between 
these results and the crystallographically derived 
structures has been analysed in an attempt o define 
how such structures actually relate to theoretical pre- 
dictions. The two test structures for this study are the 
proflavine complexes with CpG and dCpG, which 
are among the best determined crystallographically 
in these series. 
Introduction 
The interactions of the frameshift mutagen proflavine 
(Fig. 1 ) with double-stranded nucleic acids have been 
the subject of much study (reviewed, for example, by 
Gale, Cundliffe, Reynolds, Richmond & Waring, 
1981; Neidle, 1979). At a detailed structural evel, 
X-ray crystallographic analyses have elucidated the 
intercalative binding between proflavine and (i) the 
ribonucleoside phosphates CpG* (Neidle et al., 1977; 
Berman et al., 1979), 5-iodo-CpG (Reddy, Seshadri, 
Sakore & Sobell, 1979) and the ternary complex with 
CpA and UpG (Aggarwal, Islam, Kuroda & Neidle, 
1984) and (ii) the deoxyribodinucleoside phosphate 
dCpG? (Shieh, Berman, Dabrow & Neidle, 1980; 
Neidle, Berman & Shieh, 1980). All of these com- 
plexes have two antiparallel strands Watson-Crick 
hydrogen-bonded together. NMR studies have in gen- 
eral not been able to define the structures of these 
complexes in solution to a level of detail equivalent 
to that of these X-ray structures; however, a number 
of theoretical studies have been performed which 
examine drug intercalation into dinucleoside dimers 
(Pack & Loew, 1978; Ornstein & Rein, 1979; Miller, 
Brodzinsky & Hall, 1980; Malhotra & Hopfinger, 
1980; Pack, Hashimoto & Loew, 1981; Dearing, 
Weiner & Kollman, 1981 ). These studies have concen- 
trated on questions of backbone conformation, sugar 
puckers and flexibility. 
It has now been shown that all the experimentally 
observed rug-dimer duplex structures have a close 
correspondence in dinucleoside backbone torsion 
angles (Sheih et al., 1980; Berman, Neidle & Stodola, 
1978) and thus all these structures may be said to fall 
into a single conformational c ass, regardless of the 
nature of the intercalated rug. 
The present study is concerned with the question: 
given an opened-up duplex dimer of this generalized 
* Cytidylyl-3',5'-guanosine. 
t Deoxycytidylyl-3',5'-deoxyguanosine. 
H2N~NH 2 H 
Fig. 1. Proflavine. 
Methods 
All calculations and computer-graphics manipula- 
tions were performed on a PDP l l /34A computer 
linked to an interactive computer-graphics system 
(Gresham-Lion Supervisor 214). 
The energy of a particular state was calculated as 
the sum of a number of intercalation terms represent- 
ing non-bonded, torsional, electrostatic and hydro- 
gen-bond energies: 
VTO T = VN_ B -~- VTORS + VE- S -~- VH_B. 
The non-bonded parameters used were the 'soft' 
parameter set B given elsewhere (Islam & Neidle, 
1983). Hydrogen-bond parameters were from Hagler, 
Huler & Lifson (1974). 
Partial charges for the proflavine cation were calcu- 
lated using the GAUSSIAN78 ab initio computer 
programs; these were close to those reported (Dearing 
et al., 1981). Those for the dinucleosides were taken 
from Pearlstein, Dreno, Pensak & Hopfinger (1981). 
Torsion barrier heights were from Hopfinger (1973). 
Total minimization of conformational energy with 
respect to torsion angles was performed using the 
method of conjugate gradients (Fletcher & Reeves, 
1965). Convergence was judged to have been achieved 
when consecutive cycles of minimization resulted in 
no more than a 1 ° change of any torsion angle, and 
a gradient of less than 0.4kJmol -~ deg -I. Gradient 
is defined as dE~dr,  with r being a torsion angle. 
The 'soft' non-bonded parameter set allows for low- 
energy structures with slightly closer intermolecular 
non-bonded contacts than 'harder' ones and, accord- 
ingly, at least in part compensates for the use of fixed 
bond lengths and angles. It is well known that small 
changes in particularly the latter parameters can help 
to stabilize otherwise higher-energy structures. The 
minimization of the >300 bond lengths and angles 
in the structures tudied in this paper is computa- 
tionally expensive and so the use of 'soft' parameters 
is a test of their ability to relate to experimental 
structures. 
When solvent contributions were not explicitly 
modelled, either a distance-dependent formalism for 
the dielectric onstant e such that : e = 1 for r o < 3 A,  
e =0.75r 0 -  1.25 for 3 /~< r o<7/~ and e =4 for r 0< 
7 ~, or an e =r  0 model was used. Water-molecule 
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coordinates were taken directly from the crystallo- 
graphic studies. 
H-atom coordinates have been published for the 
proflavine-CpG structure (Berman et al., 1979); these 
were not obtained directly from the X-ray data, but 
were derived from standard geometric onsiderations. 
Idealized H-atom positions were calculated for the 
proflavine-dCpG structure. 
In a typical analysis, a proflavine molecule was 
manipulated by rotational and translational move- 
ments of 0.1/~, steps on a grid in the plane mid-way 
between the base pairs of the dinucleosides. This 
procedure was performed on the computer-graphics 
display whilst the intermolecular interaction energy 
was being calculated at each step. Inter- and 
intramolecular-energy minimization was then per- 
formed with such positions as starting-points, and all 
dinucleoside backbone and glycosidic torsion angtes 
taken as variables. Total minimization was not per- 
formed at each grid point, as the combined graphics- 
energy calculations were found to be readily capable 
of locating low-energy regions. A limited series of 
minimizations (not detailed below) showed the justifi- 
cation of this approach. 
Results and discussion 
(a) Intercalation in CpG from the major-groove 
direction 
Interaction from the major-groove side of CpG, 
that is with the drug's exocyclic N atoms oriented 
into the major groove and its long axis roughly 
parallel to the long axis of the base pairs, is shown 
in Fig. 2. The minimum-energy position (Table 1 and 
Fig. 3) is close to the crystallographic one, and only 
differs by being some 0.5 A deeper into the major 
groove than the latter. This is due to increased rug- 
(a) 
Fig. 2. The structure of  the prottavine complexes of (a) CpG and 
(b) dCpG,  as found in their crystal structures. The drug 
chromophore is shaded for clarity. View is onto the base-pair 
plane. 
Table 1. Intermolecular energies (kJ mo1-1) of 
proflavine intercalation 
van der Electro- Hydrogen- 
Waals static bonding Total Fig. 
CpG M (cryst.) -247.8 -200.6 -59.4 -507.8 2 
CpG M (min.) -280.5 -201.1 -63-5 -545.1 3 
CpG p (min.)* -209.4 -240.8 0 -450.2 4 
-186.0 -205.6 0 -391.6 4 
CpG"/ (min.) -113.3 -231.2 0 -344-4 5 
dCpG 'v' (tryst.) -245.8 -265.8 0 -511.6 2 
dCpG M (rain.) -258-3 -262.5 0 -520-8 3 
dCpG p (min.)* -185.5 -278.8 0 -464-4 4 
-173.1 -201.1 0 -374.2 4 
dCpG'" (min.) -95.3 -242.4 0 -337.7 5 
Abbreviations: M = major-groove intercalation; rn = minor-groove 
intercalation; p = perpendicular intercalation. 
* First line: diagonal; second line: true perpendicular. 
Table 2. Geometry of the hydrogen bonding between 
the exocyclic N atom of proflavine and a phosphate 0
atom for CiaG 
Note that since the complex has exact twofold symmetry, the 
hydrogen bonding is identical for both dinucleoside strands. 
N. . .O H-. .O /_ N -H . . .O  
Crystal structure 3-00/~ 2.00 ,~ 173 °
Minimum-energy position 2.89 1.91 165 
base overlap, resulting in enhanced van der Waals 
intercalation stabilization. Note that only about half 
of the total energy is due to this factor. The difference 
in energy between observed and calculated structures 
is 37 kJ mol -~. The flexibility [as judged by positional 
changes of the proflavine without producing sig- 
nificant changes in energy (<2kJmol-~)] of this 
proflavine within the major-groove minimum-energy 
position was restricted by the development of 
unfavourable close contacts between the proflavine 
and the atoms of ribose groups (close contacts refer 
to a situation where the distance between a given pair 
of atoms is closer than the sum of the van der Waals 
(a) 
(b/ 
Fig. 3. The minimum-energy conformations for major-groove inter- 
calation into (a) CpG and (b) dCpG. 
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Table 3. Changes in backbone torsion angle (°) produced by total-energy minimization for the major-groove 
intercalation structures 
Torsion angle about bond 
C(3')C-O(3')C O(3')C-P P-O(5')G O(5')G-C(5')G C(5')G-C(4')G 
CpG: strand 1 0-0 1.7 -2.3 -2 .9  - 1. ! 
strand 2 -0-  I -2 .6  - 1.9 -0.3 -0.1 
dCpG: strand 1 -0.7 1-6 ! .5 -2 .7 - 1-3 
strand 2 -0 .4  - 1.6 -0 .6  0.7 0.0 
radii of the atoms). The rotational flexibility of the 
proflavine molecule is limited to about 5 ° when in 
the intercalation site. The differences between the 
crystallographic and minimum-energy conformations 
will to some extent depend upon the types of energy 
formalism being employed (Islam & Neidle, 1983). 
An important factor restricting drug movement was 
found to be hydrogen bonding between the proflavine 
and the dinucleoside. In the crystallographic structure 
hydrogen bonds exist between the phosphate groups 
of the dinucleoside and the exocyclic groups of the 
proflavine (Berman et al., 1979). 
The computational model used here for hydrogen 
bonding (Hagler et al., 1974) has no explicit angular 
dependence, and thus it was of interest o compare 
the minimum-energy conformation with the crystallo- 
graphic structure. The hydrogen-bonding parameters 
are given in Table 2. Table 3 lists the changes in 
dinucleoside backbone torsion angles produced by 
energy minimization. These changes are small, and 
do not significantly alter the twofold symmetry of the 
complex. 
( b ) Perpendicular modes of binding to CpG 
Possible binding modes for this proflavine with its 
long axis perpendicular to the phosphate-phosphate 
interstrand vector (Fig. 4) were investigated. It should 
be noted that in the perpendicular mode of binding 
the proflavine molecule could be manipulated into a 
(a) 
(b) 
Fig. 4. (a )  Perpend icu la r  b ind ing  mode for CpG and (b)  d iagona l  
mode for  dCpG.  
low-energy position from both the major- and the 
minor-groove direction. The flexibility of the 
molecule in this perpendicular mode of binding was 
investigated; the minimum-energy position is shown 
in Fig. 4 and its energy given in Table 1. The 
possibilities of hydrogen-bond formation between the 
proflavine and the dinucleoside backbone were 
investigated but were limited by the development of 
unfavourable close contacts between the ribose sugars 
and proflavine atoms, thus not enabling the drug's N 
atoms to approach sufficiently close to the phosphate 
groups. It was found that in the minimum-energy 
position the long axis of the proflavine is inclined at 
about 90 ° to the phosphate-phosphate vector. It is 
noteworthy that this angle is close to that found 
between the drug daunomycin and a hexanucleotide 
(Quigley, Wang, Ughetto, van der Marel, van Boom 
& Rich, 1980). Stabilization was somewhat enhanced 
by orienting the drug diagonally, at an angle of -45  ° 
(Fig. 4), this increased both electrostatic and van der 
Waals energy stabilization compared to the perpen- 
dicular situation, with the former actually being 
greater than for major-groove intercalation (Table 1 ). 
However, the relative lack of base-drug overlap in 
either the diagonal or perpendicular bases makes 
them overall of higher energy than the major-groove 
state. 
( c) Minor-groove binding to CpG 
In this situation, the drug was docked from the 
minor-groove direction, with the chromophore orien- 
ted parallel to the P. • • P interstrand vector. A low- 
energy state analogous to the major-groove one was 
not possible; attempts were made with the exocyclic 
N atoms both facing away and towards the minor 
groove. This was ascribable to unfavourable close 
contacts developing between the drug and the ribose 
sugars. Fig. 5 shows the low-energy structure found, 
which does not have any drug-base overlap, and 
hence is some 200kJmol -~ less favourable than 
major-groove intercalation. The observed base-turn 
angle of 33 ° for the CpG-proflavine structure [defined 
as the angle subtended by the two interstrand 
C(l') • • • C(l ') vectors], has been suggested (Neidle, 
Kuroda, Aggarwal & Islam, 1983) to correlate with 
interstrand P . . .  P separation. Thus dinucleoside 
structures with smaller base-turn angles will have the 
two backbones further apart, which could result in 
some improvement in minor-groove intercalation. 
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( d) Major-groove intercalation in dCpG 
The crystallographic and minimum-energy confor- 
mations are shown (Figs. 2 and 3 respectively). It is 
notable that for the crystallographic conformation 
the intermolecular energy of binding is almost equal 
to that of the CpG-proflavine crystal structure, 
although no proflavine-dinucleoside hydrogen bonds 
exist in the deoxy structure. The minimum-energy 
position was again located by translation into the 
major groove. The changes in torsion angles after 
minimization (Table 3) were small. A prominent 
feature of the proflavine-dCpG crystal structure is 
the existence of a highly structured water network. 
The procedure for locating the approximate 
minimum-energy drug position was repeated with the 
water molecules which constituted the first hydration 
shell. There are hydrogen bonds in the crystal struc- 
ture between several water molecules and the 
proflavine N atoms. It was not possible to analyse 
fully the effects of these water molecules. Preliminary 
results, however, indicated that the calculated posi- 
tion of the proflavine was -0.4 A closer to the crys- 
tallographic position, upon minimization with solvent 
molecules present. These had the effect of making the 
drug molecule -0.4/~ less buried in the major groove. 
stabilization compared to the fully perpendicular 
case. 
(f) Minor-groove binding to dCpG 
Interaction is analogous to the CpG case, with 
steric hindrance to effective intercalation. The binding 
is thus largely a surface one, with the drug protruding 
far into the minor groove (Fig. 6). 
We are grateful to the Cancer Research Campaign 
for support (grant No. SP1384 and a Career Develop- 
ment Award to SN). 
Fig. 6. Space-filling representation f the minor-groove minimum- 
energy dCpG-proflavine structure. The drug molecule is shaded 
for clarity. 
(e) Perpendicular binding to dCpG 
Results were again very similar to the CpG struc- 
ture. In the perpendicular mode of binding the struc- 
ture is more stable than that for the CpG complex 
(Table 1 ), although the resulting structures are similar 
and the proflavine molecule lies (long axis of the 
proflavine) at about 90 ° to the P . . -P  vector. 
Diagonal binding, as in the CpG case, results in 




Fig. 5. Minor-groove interactions of (a) CpG and (b) dCpG with 
proflavine. 
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The Structure of Pilocarpine Hydrochloride, C11H17N20~.Cl-- A Muscarinic Alkaloid 
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Abstract 
M r = 244.72, at ambient room temperature (---295 K) 
and at 77 K, monoclinic, P2~, Z=2,  a = 11.057 (1) 
[10.965(5)], b=9.212(1)[9.177(3)] ,  c=6.697(1) 
[6.507(3)]A and f l=110.05(2) [109.19(4)] ° , V= 
637.8 (2) [618-4 (5)] A3 (the values in brackets for the 
77 K determination). Dx = 1.276 g cm -3, F(000) = 
260, h (MoKa)  =0.71069/~, p.(Mo Ka)= 
2"92cm -I, R=0.043 [0.031] for 2751 [3864] con- 
tributing reflections. The N-methylimidazole ring is 
protonated at the position of the secondary N atom 
and the ring is planar. The NMR spectrum of the 
compound was studied over the pH range 2.6-10.6; 
these spectra show that there is a delocalization of 7r 
electrons over the bonds between the two N atoms 
of the protonated imidazole ring. The C1- ion in the 
crystal structure is hydrogen-bonded to the proton- 
ated N atom at a distance of 3.035 (2) [3.030 (2)] A. 
The conformation of the molecule differs significantly 
from that found in pilocarpine trichlorogermanate 
and from models of muscarinic agents. 
Introduction 
Pilocarpine (1) is one of several alkaloids that mimic 
the effect of acetylcholine on autonomic effector cells 
that control smooth muscle contraction. The com- 
pound binds to the muscarinic lass of acetylcholine 
receptors (Birdsall, Burgen & Hulme, 1978) and 
exhibits partial agonist activity. 
Muscarine (2), pilocarpine (1), and acetylcholine 
(3) have considerable differences in their chemical 
* Author to whom correspondence should be addressed. 
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structures yet all bind to the muscarinic receptor while 
only acetylcholine has activity at the nicotinic recep- 
tor. An explanation for the affinity of muscarinic 
agents for their receptor has been sought in terms of 
a specific binding conformation. Three distinct 
models appear in the literature: in the first, Kier ( 1967, 
1968) predicted on the basis of extended Hiickel 
theory (EHT) that there were two preferred low- 
energy conformations of acetylcholine. One, the 
folded conformation with a hydrogen-bond acceptor 
i "3 ] 
/ (. ./!. 
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